Dudediligence.

Gilead Sciences, Inc

GILDNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

1.24B

on 2026-06-30, from 1.25B on 2024-03-31 10-Q ↗

500M1BMar2024JunSepDecMar2025JunSepDecMar2026Jun

Newest

No limit

S-3ASR of 2026-08-06. An automatic shelf: the form sets no dollar limit. None sold under it to 2026-10-05. S-3ASR ↗

5 of its filings are not read yet.

Warrants

The 10-Q filed 2026-08-06 is not read yet.

Cash

$3.18B

Operating cash flow was positive over the four quarters to 2026-06-30, so no quarters are counted. 10-Q ↗

Raised: 6 of its filings are not read yet.

Also on file: $500.0M notes, 2026-05-18 424B5 ↗